Plasminogen activator
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{STRUCTURE_1a5h| PDB=1a5h | SIZE=400| SCENE= |right| CAPTION=Human tissue plasminogen activator complex with benzamidine, [[1a5h]] }} | + | {{STRUCTURE_1a5h| PDB=1a5h | SIZE=400| SCENE= |right| CAPTION=Human tissue plasminogen activator dimer complex with benzamidine, [[1a5h]] }} |
'''Plasminogen activator''' (PLA) is a serine protease which converts plasminogen to plasmin. It includes Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA [[Urokinase]]. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2. | '''Plasminogen activator''' (PLA) is a serine protease which converts plasminogen to plasmin. It includes Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA [[Urokinase]]. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2. | ||
Revision as of 10:00, 12 November 2012
Plasminogen activator (PLA) is a serine protease which converts plasminogen to plasmin. It includes Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA Urokinase. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2.
Contents |
3D structures of plasminogen activator
1a5i – PLA residues 213-477 + EGR-CMK – Vampire bat
1bqy – PLA – Pit viper
Tissue plasminogen activator
1a5h – hTPA HC+LC + benzamidine – human
1rtf - hTPA HC+LC
1tpg – hTPA F1-G - NMR
1bda – hTPA catalytic domain (mutant) + EGR-CMK
1pk2 – hTPA kringle 2 domain + 6-aminohexanoic acid – NMR
1tpk - hTPA kringle 2 domain
1tpm, 1tpn - hTPA fibrin-binding domain – NMR
